Health
228 items · page 2 of 12
- Sunday, 1 November 2026 · From Zero's Briefs
An international study presented at the ESMO congress and published in The Lancet shows that sacituzumab tirumotecan reduces recurrences and mortality in endometrial cancer; the data are preliminary and involve more than 200 oncology centers in 29 countries. BreveNews
- Sunday, 1 November 2026 · From Zero's Briefs
A study from the University of São Paulo published in the journal Neuroscience found that excessive physical activity keeps dopamine levels elevated even during rest in the mice used in the trial; the authors note that they did not directly measure sleep or anxiety in the animals. Adnkronos
- Saturday, 31 October 2026 · From Zero's Briefs
FAO, WHO, WOAH and CMS have set out shared priorities on surveillance, data sharing and outbreak response for avian influenza, including both high- and low-pathogenicity strains, among them the H9N2 and H7 subtypes. (Zootecnica)
- Saturday, 31 October 2026 · Analysis
The Lancet Countdown 2026 report: extreme heat and the health cost of climate change
The tenth Lancet Countdown report measures the impact of the climate crisis on global health across 54 indicators: in the 2016-2023 period, extreme heat is associated with over 540,000 deaths a year.
- Saturday, 31 October 2026 · From Zero's Briefs
The Committee for Medicinal Products for Human Use of the European Medicines Agency has given a favorable opinion to six new medicines in October 2026. The Chmp also recommended five extensions of therapeutic indication for drugs already authorized in the European Union, including AstraZeneca's H5N1 pandemic flu vaccine and Novo Nordisk's insulin icodec semaglutide. (FarmaciaVirtuale.it)
- Saturday, 31 October 2026 · From Zero's Briefs
The Italian Medicines Agency, in agreement with Ema, has confirmed nine flu vaccines for the 2026-2027 season. The formulations have been updated with the switch to trivalent vaccines, as recommended by Ema. Regional vaccination campaigns began in early October, with free provision for at-risk groups identified by the Ministry of Health. (AIFA)
- Friday, 30 October 2026 · Analysis
Mental health of healthcare professionals, Italy among the highest levels in Europe
A WHO survey of almost 90,000 responses in 29 European countries places Italy among the countries with the most depressive symptoms among doctors and nurses, with a 19-point gap compared with Denmark.
- Friday, 30 October 2026 · From Zero's Briefs
Médecins Sans Frontières celebrated the discharge of patients who recovered from the Ebola virus after being treated in the province of Ituri, in the Democratic Republic of Congo. Source
- Friday, 30 October 2026 · Analysis
Lancet Countdown: heat linked to 710,000 deaths in 2023, health emergency status requested
The tenth Lancet Countdown report, signed by over one hundred institutions in more than thirty countries, records a 36% increase in heat-related deaths since the Paris Agreement and calls for climate change to be recognised as a global health emergency.
- Friday, 30 October 2026 · From Zero's Briefs
The Board of Directors of AIFA approved in October the reimbursability of Voranigo (vorasidenib), the first oral therapy for grade 2 astrocytoma or oligodendroglioma with IDH1 or IDH2 mutation, together with six indication extensions and three equivalent drugs. The news currently comes from a single source, the communication of the AIFA Board of Directors. Source
- Friday, 30 October 2026 · From Zero's Briefs
The European Medicines Agency's Committee for Medicinal Products for Human Use adopted favourable opinions in October for six new medicines, including Foundayo (orforglipron), Eli Lilly's oral GLP-1 receptor agonist, recommended for weight management and type 2 diabetes. The news currently comes from a single source, the communication of the EMA's CHMP Committee. Source
- Thursday, 29 October 2026 · Analysis
Lancet Countdown: over 700,000 heat-related deaths in 2023
The tenth Lancet Countdown report calls for climate change to be declared a global health emergency, pointing to a rise in temperature-related deaths.
- Thursday, 29 October 2026 · Analysis
EMA recommends new drug for metastatic pancreatic cancer
The European agency's scientific committee has given a positive opinion on Rasonque following a phase 3 study on 500 patients, with an assessment completed in under 150 days.
- Thursday, 29 October 2026 · From Zero's Briefs
An international Commission of The Lancet places low educational attainment, estimated at 16.1 billion disability-adjusted life years, and income inequality, at 13.8 billion, among the leading forces weighing on global health through 2100, particularly in Africa and South Asia — the only source currently available (Il Sole 24 Ore - Infodata).
- Wednesday, 28 October 2026 · Analysis
Extreme heat and health: a report calls for a global health emergency status
The tenth Lancet Countdown report links extreme heat to hundreds of thousands of deaths a year and proposes the formal recognition of climate change as a health emergency. The request has not yet been adopted either by the World Health Organization or by governments.
- Wednesday, 28 October 2026 · Analysis
Melanoma, personalized mRNA vaccine: fewer recurrences in phase 3 study
The results of INTerpath-001, presented at the Esmo congress and set to be published in NEJM, show a reduction in the risk of recurrence in high-risk melanoma when the vaccine is added to standard immunotherapy.
- Tuesday, 27 October 2026 · Analysis
Ebola in the Democratic Republic of Congo: confirmed cases surpass 10,000
The health report, with data current as of October 25, brings the toll of the Bundibugyo Ebola epidemic to 10,060 confirmed cases and 4,887 deaths, with a case fatality rate of 48.6%.
- Tuesday, 27 October 2026 · From Zero's Briefs
The phase 3 TroFuse-005 study, published in The Lancet and conducted on 776 women at 242 centers in 31 countries, indicates that the experimental drug sac-Tmt reduced the risk of death by 32% compared to chemotherapy, with median survival of 19 months versus 12. Travel Quotidiano
- Tuesday, 27 October 2026 · Analysis
New drugs, October decisions by Ema and Aifa
The European Medicines Agency's scientific committee recommends six new medicines and five extensions of use; Aifa approves reimbursement for an orphan drug for low-grade gliomas and six other indication extensions.
- Tuesday, 27 October 2026 · From Zero's Briefs
A study published on 26 October in Scientific Reports, based on World Health Organization mortality data, found an average annual increase of 5.43% in the age-standardized mortality rate for hypersensitivity pneumonitis between 1999 and 2019. The research analysed deaths of people aged 20 and over in 32 countries; among those over 40, population ageing would account for 12.2% of the observed increase. Diario del Web
Looking for Health news from a specific day?